| The role of ABC transporters in drug resistance, metabolism and toxicity | Current Drug Delivery | 2004 | 435 |
| An inventory of the human ABC proteins | Biochimica Et Biophysica Acta - Biomembranes | 1999 | 429 |
| A pivotal role for galectin-1 in fetomaternal tolerance | Nature Medicine | 2007 | 379 |
| Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients | Atherosclerosis | 2001 | 274 |
| ABCG2 -- a transporter for all seasons | FEBS Letters | 2004 | 214 |
| Single nucleotide polymorphisms modify the transporter activity of ABCG2 | Cancer Chemotherapy and Pharmacology | 2005 | 200 |
| MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping | Journal of Biological Chemistry | 2000 | 189 |
| Leptin-induced signal transduction pathways | Cell Biology International | 2004 | 164 |
| The role of multidrug transporters in drug availability, metabolism and toxicity | Toxicology Letters | 2003 | 156 |
| Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity | Journal of Allergy and Clinical Immunology | 2001 | 144 |
| The complex role of vitamin D in autoimmune diseases | Scandinavian Journal of Immunology | 2008 | 138 |
| Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters | Drug Resistance Updates | 2005 | 111 |
| Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease | Atherosclerosis | 2004 | 110 |
| Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis | Circulation | 2001 | 108 |
| Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells | Biochemical Pharmacology | 1999 | 103 |
| Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP | PLoS Pathogens | 2009 | 95 |
| Anti-factor B autoantibody in dense deposit disease | Molecular Immunology | 2010 | 82 |
| Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin | Circulation | 2002 | 81 |
| Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains | Journal of Biological Chemistry | 1999 | 77 |
| Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes | Journal of Immunology | 2002 | 72 |
| Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation | Immunology Letters | 2001 | 69 |
| Genetic diversity and zoonotic potential of human rotavirus strains, 2003-2006, Hungary | Journal of Medical Virology | 2009 | 68 |
| Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events | Circulation | 2002 | 63 |
| Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition | Biochimica Et Biophysica Acta - Biomembranes | 2005 | 60 |
| Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells | Immunology Letters | 1999 | 60 |
